Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report
- PMID: 32577237
- PMCID: PMC7303876
- DOI: 10.1002/ccr3.2706
Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report
Abstract
In primary mediastinal large B-cell lymphoma, central nervous system (CNS) relapse is an uncommon event with a dismal prognosis. We report about the successful management of CNS relapse with chemoimmunotherapy according to MATRix (methotrexate, cytarabine, thiotepa, and rituximab) protocol followed by autologous stem cell transplant.
Keywords: MATRix regimen; autologous stem cell transplant; central nervous system involvement; primary mediastinal large B‐cell lymphoma.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
None declared.
Figures
Similar articles
-
Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.Cancer. 2015 Jan 15;121(2):226-33. doi: 10.1002/cncr.29023. Epub 2014 Sep 9. Cancer. 2015. PMID: 25204639 Free PMC article. Clinical Trial.
-
Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.Hematol Oncol. 2013 Mar;31(1):10-7. doi: 10.1002/hon.2012. Epub 2012 May 18. Hematol Oncol. 2013. PMID: 22610484
-
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.Hematol Oncol. 2023 Feb;41(1):97-107. doi: 10.1002/hon.3096. Epub 2022 Dec 8. Hematol Oncol. 2023. PMID: 36314897
-
Consolidation Therapy in Primary Central Nervous System Lymphoma.Curr Treat Options Oncol. 2020 Jul 28;21(9):74. doi: 10.1007/s11864-020-00758-4. Curr Treat Options Oncol. 2020. PMID: 32725379 Review.
-
Diagnosis, prevention and treatment of central nervous system involvement in peripheral t-cell lymphomas.Crit Rev Oncol Hematol. 2021 Nov;167:103496. doi: 10.1016/j.critrevonc.2021.103496. Epub 2021 Oct 12. Crit Rev Oncol Hematol. 2021. PMID: 34653598 Review.
Cited by
-
Thinking Outside the Box in Mediastinal Lymphoma Management.Clin Hematol Int. 2023 Jun;5(2-3):177-180. doi: 10.1007/s44228-023-00045-7. Epub 2023 May 17. Clin Hematol Int. 2023. PMID: 37195392 Free PMC article. No abstract available.
-
Central nervous system metastasis in a young female patient with primary mediastinal large B-cell lymphoma: A case report and literature review.Surg Neurol Int. 2023 Jul 28;14:270. doi: 10.25259/SNI_414_2023. eCollection 2023. Surg Neurol Int. 2023. PMID: 37560590 Free PMC article.
References
-
- Martelli M, Ferreri A, Di Rocco A, Ansuinelli M, Johnson PWM. Primary mediastinal large B‐cell lymphoma. Crit Rev Oncol Hematol. 2017;113:318‐327. - PubMed
-
- Zinzani PL, Piccaluga PP. Primary Mediastinal DLBCL: evolving biologic understanding and therapeutic strategies. Curr Oncol Rep. 2011;13(5):407‐415. - PubMed
-
- Bishop PC, Wilson WH, Pearson D, Janik J, Jaffe ES, Elwood PC. CNS involvement in primary mediastinal large B‐cell lymphoma. J Clin Oncol. 1999;17(8):2479‐2485. - PubMed
-
- Papageorgiou SG, Diamantopoulos P, Levidou G, et al. Isolated central nervous system relapses in primary mediastinal large B‐cell lymphoma after CHOP‐like chemotherapy with or without Rituximab. Hematol Oncol. 2013;31(1):10‐17. - PubMed
Publication types
LinkOut - more resources
Full Text Sources